|
Volumn 86, Issue 10, 2011, Pages 891-892
|
Basophils and plasmacytoid dendritic cells are potential sources for error in flow cytometric monitoring of patients receiving anti-CD22 therapies. AKA not all anti-CD22 antibodies are created equal
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CD19 ANTIGEN;
CD22 ANTIBODY;
CD22 ANTIGEN;
CD33 ANTIGEN;
INOTUZUMAB OZOGAMICIN;
MICROSOMAL AMINOPEPTIDASE;
MONOCLONAL ANTIBODY;
UNCLASSIFIED DRUG;
ANTIGEN EXPRESSION;
B CELL LYMPHOMA;
B LYMPHOCYTE;
BASOPHIL;
FLOW CYTOMETRY;
HUMAN;
LETTER;
LIGAND BINDING;
PLASMACYTOID DENDRITIC CELL;
PRIORITY JOURNAL;
ANTIBODIES, MONOCLONAL, HUMANIZED;
ANTIGENS, CD22;
BASOPHILS;
DENDRITIC CELLS;
FLOW CYTOMETRY;
HUMANS;
|
EID: 80052903903
PISSN: 03618609
EISSN: 10968652
Source Type: Journal
DOI: 10.1002/ajh.22130 Document Type: Letter |
Times cited : (6)
|
References (7)
|